PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Hurricane outages: Analysis details the where, and who, of increased future power cuts

A new analytical tool from U-M provides guidance for municipal and emergency planning

2025-10-17
(Press-News.org) Images

 

Georgia and northern Florida are likely to be hardest hit by increasing hurricane-induced power outages along the Atlantic coast in the future, with Hispanic, non-white, low-income and elderly populations most affected, according to new research led by the University of Michigan.

 

Hurricanes are predicted to become even more frequent and severe in the coming years if the planet's temperatures rise by another 1.5 degrees Celsius over pre-industrial levels—expected by the end of the century without drastic action taken. 

 

The total 3 C rise will bring increased outages to areas that have historically seen few service interruptions, such as the northern Atlantic Coast. And those increases will nearly double the costs of outages, from today's $6.2 billion per year average to $11 billion in today's dollars.

 

The findings, funded in part by the U.S. Environmental Protection Agency and published in the journal PNAS, underscore the need for planning and resource allocations to prepare for what's coming. 

 

"There are parts of the country where we expect to see more outages, particularly northern Florida, the southern Atlantic, such as North Carolina and South Carolina, and some areas up into the mid-Atlantic," said Seth Guikema, U-M professor of civil and environmental engineering, as well as industrial and operations engineering, and co-corresponding author of the study. "Then there are areas where we have more uncertainty, places like Texas where our models suggest they'll have fewer outages."

 

Lower-income communities already experience longer waits for service restoration in some cases, and U-M's research shows that problem is likely to worsen. 

 

To produce its analysis, U-M and its research partners combined data from models and data sets covering climate, hurricanes and information about the people living in affected regions:

 

Simulated hurricanes, 28,000 of them, based on atmospheric and oceanic data, processed by co-author, Kerry Emmanuel, formerly of M.I.T. and now chief scientific officer at WindRisk Tech.

Historic outage data at the Census tract level—possibly including localized data as specific as wind characteristics, soil moisture and tree root depth.

An evaluation, based on historical hurricane tracks and projections, as well as Census data, of which groups of people would be impacted the most.

The Interruption Cost Estimate Calculator, which measures costs from outages as well as estimates the benefits of efforts to improve reliability.

 

"What we wind up with is the areas that are, and will be, at highest risk for power outages," said Zaira Pagan Cajigas, a U-M Ph.D. graduate in industrial and operations engineering and co-lead author of the research paper. "We can go further and see the population makeup in those areas, and that's how we identified that Hispanics, non-whites, low-income and elderly residents bear the brunt of these incidents."

 

Roughly 78% of major power outages in the United States result from weather events, and those events are occurring more often in recent years. Tropical cyclones are responsible for nine out of 10 major outages. As Earth exceeds the Paris Agreement warming target, they are intensifying faster, bringing more rainfall, moving more slowly and penetrating further inland.

 

"Our hope is that this analysis will help government agencies, utilities and individual businesses and residents better understand where system hardening and other climate adaptation actions need to be taken, and the potential degree of change in outage risk and costs in the future," Guikema said.
 

The research team also includes Charles Fant, Brent Boehlert and C.X. Maier of Industrial Economics Inc., and Corrinne Hartin and Marcus Sarofim of the EPA.

 

Study: Climate Change Impacts on Tropical Cyclone-Induced Power Outage Risk: Socio-Demographic Differences in Outage Burdens (DOI: 10.1073/pnas.2502266122)

END


ELSE PRESS RELEASES FROM THIS DATE:

Craters on surface of melanoma cells found to serve as sites for tumor killing

2025-10-17
Like the surface of the moon, new research published today in Cell finds the existence of craters on the surface of melanoma cells that serve as immune hubs, becoming major sites for tumor killing. These craters could serve as good markers for immunotherapy success. This research provides insight into a key function of immune check-point blockade (ICB) cancer therapy that was previously unknown. ICB works by re-activating CD8+ T cells against tumors which shrinks and eventually kills the cancer cells. However, what facilitates local tumor killing by the infiltrating CD8+ T cells has remained a ...

Research Spotlight: Mapping overlooked challenges in stroke recovery

2025-10-17
Nirupama Yechoor, MD, MSC, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in JAMA Network Open, “Coherence of Stroke Survivors’ Lived Experiences and the Stroke Specific Quality of Life Scale.” Q: How would you summarize your study for a lay audience? As doctors who care for stroke survivors, we recognize that recovery is a long journey shaped by physical, emotional, mental and social challenges that extend beyond the hospital walls. We also recognize that many changes are needed to help all stroke survivors achieve their best recovery, which means optimizing both their health and their wellbeing. ...

Geographic and temporal patterns of screening for breast, cervical, and colorectal cancer in the US

2025-10-17
About The Study: The findings of this study suggest that despite increasing screening overall, which led to reduced geographic variation in screening, local clusters of high and low screening persisted in the Northeast and Southwest U.S., respectively. Future studies could incorporate county-level health care access characteristics to explain why areas of low screening did not catch up to optimize cancer screening practices.  Corresponding Author: To contact the corresponding author, Timothy R. Rebbeck, PhD, email timothy_rebbeck@dfci.harvard.edu. To access the ...

Cannabis laws and opioid use among commercially insured patients with cancer diagnoses

2025-10-17
About The Study: This study’s findings indicate cannabis may be a substitute for opioids in the management of cancer-related pain. However, further research directly observing cannabis use is needed to evaluate the efficacy of cannabis as a treatment for cancer-related pain. Corresponding Author: To contact the corresponding author, Victoria Bethel, MSN, email vbethel@uga.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamahealthforum.2025.3512) Editor’s Note: Please see the article ...

Research Spotlight: Surprising gene mutation in brain’s immune cells linked to increased Alzheimer’s risk

2025-10-17
Dominika Pilat, PhD, and Ana Griciuc, PhD, of the Department of Neurology at Massachusetts General Hospital are the lead and senior authors of a paper published in Neuron, “The Gain-of-Function TREM2-T96K Mutation Increases Risk for Alzheimer’s Disease by Impairing Microglial Function.” Q: How would you summarize your study for a lay audience? Our team wanted to understand how immune cells of the brain, called microglia, contribute to Alzheimer’s disease (AD) pathology. It’s known that subtle changes, or mutations, in genes expressed in microglia are associated with an increased ...

Missing molecule may explain Down syndrome

2025-10-17
Faulty brain circuits seen in Down syndrome may be caused by the lack of a particular molecule essential for the development and function of the nervous system, new research suggests. Restoring the molecule, called pleiotrophin, could improve brain function in Down syndrome and other neurological diseases – possibly even in adults, the researchers say. The scientists conducted their work in lab mice, rather than in people, so the approach is far from being available as a treatment. But the researchers found that administering pleiotrophin improved brain function in adult ...

Donor diabetes and 1-year Descemet membrane endothelial keratoplasty success rate

2025-10-17
About The Study: The 1-year success rate in eyes undergoing Descemet membrane endothelial keratoplasty (DMEK) with successfully prepared tissue was very high regardless of donor diabetes status. These results, supported by the separately reported finding that endothelial cell loss and cornea morphometry after 1 year were not affected by donor diabetes status, provide strong support for having no restrictions on the use of tissue from donors with diabetes for DMEK.  Corresponding Author: To contact the corresponding author, Jonathan H. Lass, MD, email deks@case.edu. To access the embargoed study: Visit our For The Media website at this link ...

Endothelial cell loss 1 year after successful DMEK in the diabetes endothelial keratoplasty study

2025-10-17
About The Study: This randomized clinical trial found that endothelial cell loss and morphometry 1 year after Descemet membrane endothelial keratoplasty (DMEK) were not affected by cornea donor diabetes status. With comparable 1-year graft success with tissue from donors with and without diabetes demonstrated in this trial, these findings support the use of corneas from donors with diabetes for endothelial keratoplasty procedures.  Corresponding Author: To contact the corresponding author, Jonathan ...

Overactive Runx1 gene triggers early disc degeneration linked to aging

2025-10-17
“Taken together, these findings reveal a novel role of Runx1 in maintaining disc health and regulating age-related degenerative processes.” BUFFALO, NY — October 17, 2025 — A new research paper was published in Volume 17, Issue 9 of Aging-US on September 8, 2025, titled, “Runx1 overexpression induces early onset of intervertebral disc degeneration.” In this study, led by first author Takanori Fukunaga from Emory University School of Medicine and corresponding author Hicham Drissi from Emory and the Atlanta VA Medical Center, researchers found that the Runx1 gene, when overactive in spinal disc cells, ...

NYU Langone Health chair of ophthalmology, Dr. Kathryn Colby, honored with Castroviejo Medal at AAO 2025

2025-10-17
ORLANDO, FLORIDA, OCTOBER 17, 2025—NYU Langone Health ophthalmology faculty present their latest research at this year’s annual meeting of the American Academy of Ophthalmology (AAO), where Kathryn A. Colby, MD, PhD, the Elisabeth J. Cohen, MD, Professor and chair of the Department of Ophthalmology at NYU Grossman School of Medicine, will be awarded the prestigious Castroviejo Medal from the Cornea Society. This honor recognizes Dr. Colby’s groundbreaking contributions to the field of ophthalmology, particularly in the promotion, research, and understanding of the cornea. Among the presentations at AAO in Orlando, October 17 ...

LAST 30 PRESS RELEASES:

Invisible poison: Airborne mercury from gold mining is contaminating African food crops, new study warns

Nearly half of Finns with chronic conditions find medication therapy a burden

Do animals fall for optical illusions? What fish and birds can teach us about perception

New guideline emphasizes conversations about mood, mental health between patients and clinicians

Children’s Hospital of Philadelphia researchers observe significant reduction in diagnosis of food allergies following expert guidelines encouraging early peanut exposure

ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma

Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer

ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy

Drug combo cuts risk of death in advanced prostate cancer by 40%

ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors

Novel treatment combination improves progression-free survival in metastatic, estrogen-receptor-positive HER-2-negative breast cancer

ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients

ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer patients

New generation of Antibody-Drug Conjugates (ADCs) shows unprecedented promise in early-stage disease

Sylvester Cancer Tip Sheet for October 2025

Three science and technology leaders elected to Hertz Foundation Board of Directors

Jump Trading CSO Kevin Bowers elected to Hertz Foundation Board of Directors

Former Inscripta CEO Sri Kosaraju elected to Hertz Foundation Board of Directors

Citadel’s Jordan Chetty elected to Hertz Foundation Board of Directors

McGill research flags Montreal snow dump, inactive landfills as major methane polluters

A lightweight and rapid bidirectional search algorithm

Eighty-five years of big tree history available in one place for the first time

MIT invents human brain model with six major cell types to enable personalized disease research, drug discovery

Health and economic air quality co-benefits of stringent climate policies

How immune cells deliver their deadly cargo

How the brain becomes a better listener: How focus enhances sound processing

Processed fats found in margarines unlikely to affect heart health

Scientists discover how leukemia cells evade treatment

Sandra Shi MD, MPH, named 2025 STAT Wunderkind

Treating liver disease with microscopic nanoparticles

[Press-News.org] Hurricane outages: Analysis details the where, and who, of increased future power cuts
A new analytical tool from U-M provides guidance for municipal and emergency planning